Antithymocyte of globulin (ATG)-based therapy in patients with myelodysplastic syndromes

S. Yazji, F. J. Giles, A. M. Tsimberidou, E. H. Estey, H. M. Kantarjian, S. A. O'Brien, R. Kurzrock*

*Corresponding author for this work

Research output: Contribution to journalReview articlepeer-review

78 Scopus citations

Fingerprint

Dive into the research topics of 'Antithymocyte of globulin (ATG)-based therapy in patients with myelodysplastic syndromes'. Together they form a unique fingerprint.

INIS

Immunology and Microbiology

Pharmacology, Toxicology and Pharmaceutical Science